Select Page

We are heading to Sachs’ 16th Annual European Life Sciences CEO forum to discuss the latest data package generated by Adoram Therapeutics. Not only do we show superior efficacy, but more importantly improved safety compared to competitors thanks to our unique MoA. Reach out if you are around in Zurich or come in for the Rising Biotech Stars Session presentation by David Pejoski.